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The identification of bivalent aptamers for thrombin by SELEX and single-step selection 
are compared using next generation (massively parallel) sequencing and motif finding 
informatics. Results show that similar aptamers are identified by both methods. 
 
Nucleic acid aptamers are high affinity binding molecules that have applications in 
diagnostics, therapy and separation science. They are normally identified by screening 
combinatorial (randomized) libraries of typically 1012 – 1016 oligonucleotides for sequences 
that bind to a chosen target molecule by a process called SELEX (Systematic Evolution of 
Ligands by Exponential Enrichment) that consists of multiple cycles of selection and PCR 
amplification.1-3 In the selection step oligonucleotides compete for binding sites on the 
target molecule and in the amplification step the remaining pool of oligonucleotides is 
enriched with sequences that bind. The stabilities and/or affinities of aptamers based on 
natural nucleotide bases can be improved by incorporation of chemically modified bases, 
but these are more difficult to amplify. Aptamers based on locked nucleic acids (LNAs) 
would be more stable in vivo because they are resistant to nuclease enzymes, but when 
Vester and colleagues carried out 7 cycles of partitioning and amplification with a library 
that contained LNA bases they found the ratio of these bases to natural bases decreased in 
every cycle of amplification.4 Gold and colleagues have used SELEX to identify high affinity 
aptamers based on chemically modified DNA bases, but these bases must be reformatted 
onto natural bases for amplification and back onto modified bases for selection.5-7 These 
complications would be avoided if it was possible to identify aptamers without multiple 
cycles of selection and amplification.  
 
Several groups have developed alternatives to SELEX based on single-step methods of 
selection.8-11 Krylov and colleagues used Non-SELEX to identify aptamers that inhibit an 
enzyme that promotes cell division.8 A combinatorial library of single stranded DNA was 
incubated with the target substance and unbound sequences were eliminated by capillary 
electrophoresis (CE). Sequences that remained bound to the target substance and 
sequences that dissociated during CE were retained and subjected to a further round of CE. 
Sequences in the fraction that was collected after three rounds of CE were cloned and 
Sanger sequenced. Nitsche and colleagues used MonoLEX to identify aptamers that bound 
to virus particles.9 A DNA library was applied to an affinity column with heat-inactivated 
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virus particles attached to a solid support. The column was washed to eliminate weakly 
bound DNA and then physically cut into sections. DNA in the sections was amplified and 
pyrosequenced. While these methods show that aptamers can be identified by single-step 
selection they were not carried out in parallel with SELEX and therefore it is not known if 
they produce comparable results. 
 
In this paper we describe the parallel selection of bivalent aptamers for thrombin by SELEX 
and single-step selection. Thrombin is a multifunctional serine protease that plays important 
roles in blood clotting.12,13 The dominant structural feature of the 37 kDa protein is a deep 
negatively charged active site and adjacent hydrophobic pocket flanked at either-end by 
positively charged regions known as exosites I and II. Exosite I is the binding site for multiple 
macromolecular and low molecular weight ligands including fibrinogen, thrombomodulin, 
hiridin and heparin cofactor II, and exosite II is the binding site for heparin and platelet 
receptor GPIb-IX-V. Interactions between all three sites mediate blood clotting. DNA 
aptamers that bind to both exosites are known.14 Apt-15 (5’-GGTTGGTGTGGTTGG) binds to 
exosite I and inhibits the conversion of soluble fibrinogen to insoluble fibrin,15 and Apt-29 
(5’-AGTCCGTGGTAGGGCAGGTTGGGGTGACT) binds to exosite II but only has a moderate 
effect on the conversion of fibrinogen.16 Mayer and colleagues have shown that the 
inhibition of blood clotting is enhanced when APT-15 is connected to higher affinity APT-29 
by a 15 base poly-dA linker,17 and Soh and colleagues have shown that linkers identified by 
selection are superior to designed linkers.18  
 
 
Figure 1 Structure of the combinatorial library that was screened for bivalent aptamers. 
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The structure of the DNA library screened for bivalent aptamers is shown in Figure 1.  
Individual oligonucleotides consist of a 30 base combinatorial (randomized) sequence 
bracketed by APT-15 and Apt-29, and primer sequences for PCR. The PCR primers used by us 
are the same as those used by Tassett and colleagues in the original selection of APT-29.16 
Selection was carried out with magnetic beads coated with thrombin conjugated to biotin 
polyethylene glycol (biotin-PEG). Before conjugation thrombin was characterized with 
antibodies and aptamers, and by MS, electrophoresis and western blotting as described 
previously.14 PEG is a flexible linear polymer with low non-specific binding properties for 
biological molecules. The PEG used in this work had an extended length of approximately 3 
nm; for comparison thrombin has dimensions of 4.5 x 4.5 x 5.0 nm.13 The conjugation 
method was designed to minimize the number of biotin-PEG molecules attached to each 
molecule of thrombin. Counter-selection was carried out with a mixture of beads consisting 
of equal amounts of uncoated streptavidin beads, beads coated with biotin-PEG and beads 
coated with human serum albumin (HSA). HSA was characterized and biotinylated in the 
same way as thrombin. 
 
The workflow for SELEX is shown in Figure S3 (see supporting information). Five nanomoles 
of library (3 x 1015 oligonucleotides) was thermally conditioned in HEPES buffer (40mM 
HEPES, 125 mM NaCl, 5 mM KCl, 1 mM, MgCl2, 1 mM CaCl2, 0.05% Tween-20, pH 7.5) by 
heating to 95oC, and then cooled to 4oC and allowed to attain room temperature. In the first 
round of selection the library was slow-tilt rotated with thrombin-coated beads in 50 ml of 
HEPES buffer containing 0.1 mg ml-1 HSA and 1 μM poly(deoxyinosinic-deoxycytidilic) acid 
for one hour, and then the beads were magnetically precipitated and washed with HEPES. 
DNA bound to the beads was amplified with a 5’-biotin antisense primer for the number of 
cycles required to produce an intense band at 119 bp in PAGE (Figure S4a; see supporting 
information) and then products of this length were extracted by preparative electrophoresis 
on 2% agarose (Figure S4b; see supporting information). Extracted products were converted 
to single stranded DNA with streptavidin magnetic beads and NaOH as describe previously,19 
and fed into the next round of selection. Stringency was increased in each round of selection 
by decreasing the concentration of DNA and the amount of thrombin-coated beads, and 
counter selection was carried out in rounds 3 and 5.  
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Figure 2 a) Scheme of single step selection. Key: size selection = preparative electrophoresis; 
QC = quality control; NGS = next generation sequencing. b) Detail of one cycle of 
dissociation. Thrombin-coated magnetic beads (MBs) with bound DNA are incubated for 
time t and then magnetically precipitated. DNA in the supernatant was extracted and fed 
into PCR I, and the MBs were re-suspended for a new cycle of dissociation. c) Bar-chart 
showing durations (t) of dissociation cycles. 
 
The workflow for single-step selection is shown in Figure 2a Five nanomoles of thermally 
conditioned library in HEPES buffer containing HSA and poly-IC was rotated with the 
counter-selection mixture of magnetic beads for 24 hours. The counter-selection beads 
were precipitated and the supernatant was rotated with thrombin-coated beads for 48 
hours. The beads were then precipitated and re-suspended in HEPES buffer for nine cycles 
of dissociation (Figure 2b). The durations of the dissociation cycles are shown in Figure 2c; 
the total time for all cycles (96 hours) is equivalent to 50 x the half-life of a binding molecule 
with a dissociation rate constant (kd) of 1 x 10
-4 s-1;  monoclonal antibodies have kd values in 
the range 10-2 – 10-4 s-1 and APT-29 has kd values in the range 0.82 – 2.86 x 10
-3 s-1.20-22 At 
the end of each dissociation cycle the beads were precipitated and the supernatant was 
retained. DNA was extracted from the supernatants with charge-switch magnetic beads and 
amplified for 20 cycles of PCR. DNA that remained bound to the beads after 9 dissociation 
cycles was amplified by heating the beads in PCR buffer to 95oC for 15 minutes followed by 
addition of polymerase and 15 cycles of PCR. PCR products visualized by PAGE (Figure S2; 
see supporting information).  
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Figure 3 a) Motif finding informatics as applied to DNA retained on the beads in single-step 
selection. Key: numbers in rectangles show the number of sequences at each stage in the 
pipeline. b) Linkers 4 -6 identified in round 5 of SELEX.  
Samples from SELEX and single-step selection were amplified with barcoded primers (for 
sequences see Table S3 in supporting information) as shown in Tables S1 and S4 (see 
supporting information), using nested PCR as shown in Figure S5a (see supporting 
information). Next generation sequencing (NGS) was carried out on a 454 GS FLX platform 
using titanium chemistry according to manufacturer’s instructions. Reads were sorted by 
barcode and sequences nested between the aptamers were extracted; an average of 28,640 
nested sequences was obtained from each cycle of single-step selection, and an average of 
34,299 nested sequences was obtained from each round of SELEX. Sequences were then 
processed as shown in Figure 3. Any sequences that were not 30 bases long were discarded 
(length filter) and duplicate sequences were discarded in the single-step method (unique 
filter), but not in SELEX. The remaining sequences were searched for motifs with MEME4.9.0 
downloaded onto a Linux machine and executed locally.23 Figure 3a shows the three most 
abundant motifs in DNA still bound to the beads in the single step method. The location of 
each motif in the 30 base sequence was plotted against its abundance (number of 
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sequences with motif divided by total number of sequences) and then the consensus of 
sequences with the motif located at the mean position was determined with Clustal 
Omega.24 Figure 3 shows that consensus sequences based on the two most abundant motifs 
(linkers 1 and 2) in the single step method are very similar to consensus sequences based on 
the two most abundant motifs (linkers 4 and 5) in SELEX. The consensus sequence based on 
the third most abundant motif in the single-step method (linker 3) is a blend of linkers 1 and 
2. Figure 4 shows how the abundance of the motifs changed in each cycle of dissociation 
and each round of SELEX. In the single-step method most of the enrichment occurred in the 
last 4 cycles, but no peak was reached suggesting that further enrichment could be achieved 
by additional cycles. The initial increase of motifs 4 and 5 followed by a plateau is typical of 
SELEX,25 and shows that enrichment was complete after three or four rounds. Linker 6 is 
different; it was first detected at low (0.01%) abundance in Round 4 and then increased 
more rapidly than any other motif in Round 5. 
 
Figure 4 Bar graphs showing enrichment of motifs in each cycle of single-step selection and 
each round of SELEX. 
Lowest energy secondary structures corresponding to linker sequences bracketed by the 
aptamers and PCR priming sequences were determined with mfold (for structures see 
Figures S8–S10 in the supporting information).26 Table 1 shows the amount of base-pairing 
between the aptamers and the scaffold (linker and primer sequences). The structure of the 
bivalent aptamer based on linker 2 is shown in Figure 5a. Structures based on linker 1 and 
linkers 3–5 are similar to structure 2, with double stranded regions formed by extensive 
base-pairing between the linker and the scaffold. The structure of the bivalent aptamer 
based on linker 6 is different because there is base-pairing between the scaffold and APT-
29. Bivalent aptamers with linkers 1–6 were investigated for their ability to inhibit the 
thrombin-catalyzed conversion of fibrinogen to fibrin; APT-15, Apt-29 and argatroban (a 
small molecule inhibitor of thrombin) were also investigated. The aptamers were thermally 
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conditioned and incubated with 1 nM thrombin for one hour at 25oC. Then fibrinogen was 
added to a final concentration of 1 mg ml-1 and the increase in optical density (OD) was 
monitored at 340 nm. The increase had a sigmoid profile where the duration of the initial 
lag-phase is dependent on the concentration of the inhibitor (Figure S11; see supporting 
information). Plots of lag-phase against inhibitor concentration are shown in Figures S12-14 
(see supporting information) and the aptamer concentrations required to produce half-
maximal inhibition of thrombin (IC50 concentrations) are listed in Table 1. Thrombin 
inhibition assays are an indirect measure of binding to thrombin and therefore aptamers 
were also investigated in affinity assays. Thrombin was adsorbed on the walls of a multiwall 
plate and incubated with thermally conditioned aptamers modified at the 5’-end with 
biotin. After washing away unbound aptamers, the plate was incubated with streptavidin 
peroxidase for one hour and then with and tetramethylbenzidine/H2O2 solution. Color 
development was stopped after 10 minutes with 1M H2SO4 and the absorbance at 450 nm 
was determined. All aptamers except Apt-15 had affinities that were similar to their IC50 
values as shown in Table 1. The lower affinity of APT-15 is probably because the inhibition 
assays were homogenous, but the affinity assays involved a series of incubations and 
washing steps. Apt-15 is known to have a faster dissociation rate constant than Apt-29,20-22 
and therefore more dissociation during washing and incubation steps is expected.   
 
 
 
 
 
Figure 5 a) Structure of bivalent aptamer based on Linker 2. b) Structures of truncated 
derivatives of bivalent aptamer based on linker 2; excised bases are shown as grey circles. 
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Table 1 IC50 values, affinities and base pairing between scaffold and linker in bivalent 
aptamers. 
Aptamer       IC50 (nM) 50% Affinity (nM) Base-pairing   
Linker         Apt-15        Apt-29 
1     2.7  1.4   1  0 
2     0.6  0.2   0  0 
3     1.1  0.4   2  0  
4     1.0  0.4   0  0  
5     1.5  1.0   2  0 
6     24.5            ~20.0    2  11 
Apt-29              >1000  0.7   -  - 
Apt-15    6.0            >1000    -  - 
Argatroban   1.80     -   -  - 
I          0  0 
II                    0  0 
III                  0  0  
IV    >1000           >1000   -  - 
 
An important requirement for any bivalent aptamer is the absence of internal conflict (intra-
strand base-pairing) between the linker and the aptamers. Table 1 shows that all linkers 
selected, with the exception of linker 6, have no base-pairing with APT-29, and low or zero 
base-pairing with APT-15. Only linker 6 permits base-pairing with APT-29 and this explains 
why the bivalent aptamer based on this linker has the lowest affinity and highest IC50 value 
of all the bivalent aptamers that were investigated. Three of the linkers (linkers 1, 3 and 5) 
permit the formation of 1 or 2 base pairs between APT-15 and the scaffold. The lower 
affinities and IC50 values of these bivalent aptamers compared with the bivalent aptamer 
based on linker 2 shows that even low amounts of internal conflict can impair function. The 
lowest energy structure of the bivalent aptamer based on linker 4 has no base-pairing with 
APT-15, but further analysis shows that it can fold into two other structures, one of which 
does permit the formation of 2 base pairs with Apt-15 (see supporting information). The 
free-energies of these structures are so similar that some folding into all three is probable. 
By contrast the bivalent aptamer based on linker 2 can only fold into the single structure 
shown in Figure 5a. This difference could account for the slightly lower affinity of the 
bivalent aptamer based on linker 4. The bivalent aptamers based on linkers 1-5 all have 
extensive base pairing between the linker and the scaffold. To understand why this was 
selected we obtained truncated derivatives of the bivalent aptamer with linker 2 as shown 
in Figure 5b and investigated them in inhibition and affinity assays. Results shown in Figures 
S14 and S18 (see supporting information) and summarized in Table 1 show that removal of 
the base pairing had no effect. The inhibition and affinity assays were carried out with pure 
aptamers, but selection was carried out in the presence of other sequences.  Some of these 
other sequences would have had the potential to hybridize with the aptamers. All of the 
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double-stranded regions in the bivalent aptamers stabilize the stem of APT-29 and we 
suggest that this protects it from disruption during selection. Thus the two main properties 
selected are absence of internal conflict between the linker and the aptamers, and 
cooperation between the linker and APT-29 to protect the latter from inter-strand conflict 
during selection. 
 
Our results show that single-step selection can produce similar results to SELEX. Further 
confirmation is provided by comparison with recent work by Soh and colleagues who 
started with a combinatorial library with the same general structure as in Figure 1, except 
that the combinatorial sequence had a length of 35 bases and the priming sequences were 
different.18 After 5 rounds of high-stringency SELEX they Sanger-sequenced 10 clones. They 
were unable to identify any consensus motifs (we would have reached the same conclusion 
if we had used Sanger sequencing instead of NGS) but like us they observed extensive base 
pairing between the scaffold We investigated the highest affinity bivalent aptamer 
identified by them (TBV-08) and found that it had an IC50 value of 0.64 nM, which is almost 
identical to the IC50 value of the bivalent aptamer based on linker 2 (see Table 2). When 
SELEX was discovered in 1990 the most effective way to determine which sequences had 
been selected was to clone them in bacteria and then sequence DNA from individual clones 
using first generation sequencing (Sanger sequencing), but it is now possible to sequence 
large numbers of DNA molecules in parallel using NGS. When combined with motif finding 
informatics this allows aptamers to be identified after fewer rounds of selection27 or even, 
as we have shown here, after a single selection step. We anticipate that in future this will 
make it easier to select aptamers with improved properties based on chemically modified 
nucleic acids.  
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Supporting Information 
 
Materials  
Oligonucleotides (all HPLC purified), avidin, Type 1 Gel Loading Solution, 4-
hydroxyazobenzene-2-carboxylic acid (HABA), human serum albumin (HSA), fibrinogen, 
salmon sperm DNA, poly(deoxyinosinic-deoxycytidilic) acid (poly-IC), 10 x TBE buffer and 
tetramethylbenzidine (TMB) solution containing 0.006 % H2O2 were from Sigma. All as-
supplied oligonucleotides were characterized by UV/vis spectroscopy using ODs returned by 
OligoCalc (http://www.basic.northwestern.edu/biotools/OligoCalc.html)S1 and PAGE. In 
general short oligos had concentrations that were in agreement with the supplier’s data 
sheet, but long oligos were typically 10% less concentrated. PAGE with silver-staining of 
aptamers showed single bands of the correct size. 4-(2-hydroxyethyl)piperazine-1-
ethanesulfonic acid (HEPES), NaCl, NaHCO3, NaOH, NaHPO4, KCl, MgCl2, CaCl2, sodium 
citrate, bovine serum albumin (BSA), water and Tween-20 (all molecular biology grade) were 
also from Sigma. Thrombin (3068 NIH units mg-1) was from Enzyme Research Laboratories, 
Swansea, UK.S2 MyOne streptavidin magnetic beads and Charge Switch magnetic beads 
were from Life Technologies. MyTaq HS DNA Polymerase and Reaction Buffer were from 
Bioline. The MinElute PCR Purification Kit was from Qiagen. EZ-Link NHS-PEG12-
Biotin (biotin-PEG-NHS) and 7k MWCO Zeba Spin Desalting Columns were from Thermo 
Scientific. 1.5 ml DNA Lo-Bind tubes were from Fisher Scientific. Streptavidin Peroxidase was 
from Abcam, Cambridge, UK. Mini-PROTEAN TGX Precast gels were from Bio-Rad. The 
PlusOneTM DNA Silver Staining Kit was from GE Healthcare. 
 
Equipment 
UV/vis spectra were recorded on a Hewlett Packard 8452A Diode Array Spectrophotometer. 
Magnetic separations were carried out with either DynaMagTM-50 magnet or a DynaMagTM-
2 magnet (both Life Technologies), and slow-tilt rotation was carried out with an MX2 
sample mixer (Life Technologies). DNA of defined length was extracted from PCR products 
with a Pippin Prep preparative electrophoresis platform (Sage Science). Extracted DNA was 
characterized with a Qubit 2.0 Fluorometer (Life Technologies) and Bioanalyzer 2100 
(Agilent). Thrombin affinity and inhibition assays were carried with a Benchmark microplate 
reader (Biorad). 
 
Biotin-PEG-Thrombin 
The contents of each vial of as-supplied thrombin were dissolved in 47.5 μl of molecular 
grade water to give a 6.55 mg ml-1 solution (8.4 x 10-9 moles) in 0.1 mM sodium citrate 
buffer, pH 6.5, containing 0.4 M NaCl and 0.2% PEG-8000. A molar equivalent of biotin-PEG-
NHS; MW = 941.09 in 5 μl of dry DMSO was added to the solution with gentle mixing, 
followed immediately by  47.5  μl of 1M sodium bicarbonate solution. The bicarbonate 
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solution increases the pH to 8.0 and initiates aminolysis of the NHS when the solution is 
homogenous. After gentle mixing for 1 hour, biotinylated thrombin was purified on a Zeba 
spin-column with water as the eluant. The concentration of thrombin in the eluate was 
determined using an extinction coefficient of E280 1% = 18.3. HSA was biotinylated in the 
same way (E280 1% = 5.31). 
 
Biotin Assay 
HABA was dissolved in 10 mM NaOH to a final concentration of 2.42 mg ml-1. Avidin was 
dissolved in 50 mM sodium phosphate buffer, pH 6.0, containing 0.15 M NaCl to a final 
concentration of 0.5 mg ml-1. A 50 µM solution of biotin was prepared in 50 mM sodium 
phosphate buffer. A calibrator solution was prepared by adding 61.52 µl of HABA solution to 
2.4 ml of avidin solution. A calibration graph was prepared by measuring the absorbance at 
500 nm 10 minutes after adding 2 µl increments of biotin solution to 100 µl of calibrator 
solution. The concentration of biotin in biotinylated thrombin was determined by measuring 
the decrease in absorbance at 500 nm 10 minutes after adding 5 µl of purified biotin–
thrombin to 100 µl of calibrator solution. 
 
Magnetic Beads For Selection And Counter Selection 
MyOne streptavidin magnetic beads (Invitrogen) were washed in HEPES buffer (40mM 
HEPES, 125 mM NaCl, 5 mM KCl, 1 mM, MgCl2, 1 mM CaCl2, 0.05% Tween-20, pH 7.5) and 
slow-tilt rotated for 1 hour with biotin-PEG-thrombin in HEPES buffer at a concentration of 
40 μg of  thrombin per mg of beads. Then the beads were washed with 4 x 1 ml of HEPES. 
HSA beads were prepared by rotating beads with biotin-PEG-HSA in the same way. PEG 
beads were prepared by rotating beads with biotin-PEG-COO- (biotin-PEG-NHS that had 
previously been incubated in 1 M sodium bicarbonate solution overnight to hydrolyze the 
NHS ester.     
 
Single-Step: Counter Selection And Selection 
A library solution was prepared by dissolving 5 nanomoles of library template 
(AGATGCCTGTCGAGCATGCTGGTTGGTGTGGTTGGN(30)AGTCCGTGGTAGGGCAGGTTGGGGG
AGTAGCTAAACTGCTTTGTCGACGGG) where N(30) is a 30-mer combinatorial (randomized) 
sequence, underlined sequences are APT-15 (GGTTGGTGTGGTTGG) and APT-29 
(AGTCCGTGGTAGGGCAGGTTGGGGGA), and sequences in bold font are for PCR, in 0.5 ml of 
HEPES buffer. The library solution was thermally conditioned at 95oC for 10 minutes, cooled 
to 4oC, and allowed to attain room temperature. It was then added to 49.5 ml of selection 
buffer (HEPES buffer containing 0.1 mg ml-1 HSA and 1 μM poly-IC) containing 1 mg of 
uncoated streptavidin beads, 1 mg PEG beads and 1 mg beads HSA beads. The beads were 
rotated with the library solution at room temperature for 24 hours and then precipitated for 
one hour on a DynaMagTM-50 magnet. The supernatant was transferred to a second tube 
and placed on a DynaMagTM-50 magnet for one hour. The supernatant was then transferred 
to a third tube to which 2 mg of thrombin beads was added and rotated for 48 hours. The 
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beads were precipitated with a DynaMagTM-50 magnet and transferred to a DNA Lo-Bind 
tube in 1 ml of HEPES buffer and immediately precipitated with a DynaMagTM-2 magnet. The 
supernatant was discarded and the beads were washed with 3 x 1 ml of HEPES. The beads 
were them suspended in beads 1 ml of HEPES and immediately precipitated with the 
supernatant retained as Supernatant 1. Other supernatants were obtained in the same way 
at the times listed in Table S1. After removing Supernatant 9 the beads were suspended in 
400 µl of water and retained.   
 
Table S1 Times at which supernatants were collected in single-step selection, barcodes of 
sequencing primers (see Table 4) that were used to amplify DNA from these supernatants, 
and number of nested PCR cycles (n) used to attach primers (see Table S3 for sequences of 
primers) for sequencing. 
 
Supernatant    Time                       Sense Primer         Antisense Primer    n 
  
1  0 minutes  MID 1   MID 8   3 
 
2   30 minutes  MID 2   MID 10  3 
  
3   90 minutes  MID 3   MID 11  3 
 
4   3 hours  MID 4   MID 13  3 
 
5  6 hours  MID 5   MID 14  6 
 
6  12 hours  MID 1   MID 8   6  
 
7  24 hours  MID 2   MID 10  6 
  
8  48 hours  MID 3   MID 11  6 
  
9   96 hours   MID 4   MID 13  9  
 
Beads  96 hours  MID 5   MID 14  3 
 
Single-Step: Extraction Of DNA From Supernatants 
1 ml of retained supernatant from a vial on the DynaMagTM-2 magnet was added to 200 µl 
of charge-switch purification buffer and 20 µl of charge-switch magnetic beads in a new Lo-
Bind tube. After rotating for 15 minutes the beads were precipitated and the supernatants 
discarded. The beads were washed with 2 x 150 µl of charge-switch wash solution and re-
suspended in 20 µl of 10 mM Tris buffer, pH 8.5.  
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Single-Step: PCR  Amplification Of DNA From Supernatants 
20 µl aliquots of Tris buffer from charge-switch beads were mixed with 50 µl of PCR solution 
I containing primers and Reaction Buffer, and 30 µl polymerase solution containing 5 units 
of DNA Polymerase in molecular grade water to give final concentrations of 1 x Reaction 
Buffer (1 mM dNTPs, 3 mM MgCl2) and 1 µM primers (sense primer: 5’-
AGATGCCTGTCGAGCATGCT; antisense primer: biotin-5’-CCCGTCGACAAAGCAGTTTAGCTAC). 
The mixture was then amplified  (60s at 95oC; 20 cycles of 95oC for 15 seconds, 60oC for 15 
seconds, 72oC for 10 seconds; final extension at 72oC for 60s). PCR products were 
characterized by mixing 4:1 with loading buffer followed by electrophoresis of 10 μl aliquots 
on 15% polyacrylamide gels in TBE buffer for one hour at 200V, and silver-staining with a 
PlusOneTM DNA Silver Staining Kit according to the supplier’s instructions. 
 
Single-Step: PCR  Amplification Of DNA Retained On Magnetic Beads  
20 µl aliquots of beads in water were mixed with 50 µl of PCR solution I. The mixture was 
heated to 95oC for 15 minutes and then cooled to 50oC for five minutes. Then the solution 
was mixed with 30 µl of polymerase solution and amplified (60s at 95oC; 15 cycles of 95oC 
for 15 seconds, 60oC for 15 seconds, 72oC for 10 seconds; final extension at 72oC for 60s). 
Products were characterized by electrophoresis. 
 
SELEX: First Round Selection  
5 nanomoles of thermally conditioned library template in 0.5 ml of HEPES buffer was added 
to 49.5 ml of selection buffer containing 200 µg of thrombin beads and rotated for one hour 
at room temperature. The beads were then precipitated for one hour on a DynaMagTM-50 
magnetic separator and washed with 4 x 1 ml HEPES buffer on a DynaMagTM-2 magnetic 
separator. The beads were then re-suspended in 340 µl of molecular grade water. 
 
SELEX: PCR Amplification Of DNA Retained On Magnetic Beads In First Round Selection 
Step 
20 µl aliquots of beads in water were mixed with 50 µl of PCR solution I. The mixture was 
heated to 95oC for 15 minutes and cooled to 50oC for 5 minutes. Then 30 µl of polymerase 
solution was added and the mixture amplified (60s at 95oC; 20 cycles of 95oC for 15 seconds, 
60oC for 15 seconds, 72oC for 10 seconds; final extension at 72oC for 60s).  
 
SELEX: Strand Separation Of PCR Products 
8 x 100 µl of pooled PCR products were transferred into 4 x 30 µl of 10 mM Tris-HCl buffer, 
pH 8.0, with a MinElute PCR Purification Kit according to the supplier’s instructions. 119 bp 
DNA was extracted with a Pippin Prep by applying each 30 µl aliquot to one lane of a 2% 
agarose cassette (Sage Science). Extracted products were pooled and converted to single-
stranded DNA (ssDNA) with streptavidin beads pre-conditioned in 20 mM NaOH as 
16 
 
described previously.S3 The yield of single-stranded DNA was estimated using an OD of 1.0 
for 0.786 µM solution. 
SELEX: Second And Fourth Round Selection Steps 
Thermally conditioned ssDNA was mixed with B µg of thrombin beads in selection buffer; 
the amounts of beads in mg and concentrations of DNA are listed in Table S2. The mixture 
was rotated for one hour and then the beads were precipitated and washed with 4 x 1 ml 
HEPES on a DynaMagTM-2 magnetic separator. The beads were then re-suspended in 2B µl 
of molecular grade water. 
Table S2 SELEX: Concentrations of DNA, magnetic beads and number of additional PCR 
cycles.                                                                    ……………………  Beads / μg  ………………… 
Round   Volume /ml       DNA /nM          Thrombin (B)    HSA  PEG   Streptavidin           N  
1   50.0              100         200       0    0 0         N/A 
2   3.0             10                     150          0        0       0                   3 
3   3.0                    10                     150        50    50     50          6  
4   3.0                    1         100       0         0      0                    3 
5   3.0                    1         100           50      50    50          3 
 
SELEX: Third And Fifth Round Selection Steps 
The method was identical to even numbered selection rounds except that single-stranded 
DNA was first rotated with a counter-selection mixture of HSA beads, PEG beads and 
streptavidin beads; the amounts of beads are listed in Table S2. After one hour counter-
selection beads were removed by magnetic precipitation and the supernatant was mixed 
with thrombin beads and rotated for one hour. 
 
SELEX: PCR Amplification Of DNA Retained On Magnetic Beads In Second And Subsequent 
Selection Rounds 
PCR amplification was carried out in two stages. In the first stage 20 µl aliquots of thrombin 
beads in water from the selection step were mixed with 50 µl of PCR solution I, heated to 
95oC for 15 minutes and cooled to 50oC for 5 minutes. Then 30 µl polymerase solution was 
added and the mixture was amplified (60s at 95oC; 10 cycles of 95oC for 15 seconds, 60oC for 
15 seconds, 72oC for 10 seconds; final extension at 72oC for 60s). PCR products were pooled 
and in the second stage 20 µl aliquots were added to 50 µl of PCR solution I and 30 µl 
polymerase solution and amplified (95oC for 60s; N cycles (Table S2): 95oC for 15s, 60oC for 
15s, 72oC for 10s; final extension at 72oC for 60s.  
 
Preparation Of Samples For Sequencing  
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20 µl aliquots of PCR I products were mixed with 50 µl of PCR solution II containing 454 
sequencing primers (Table S3) and Reaction Buffer, and 30 µl polymerase solution 
containing 5 units of DNA Polymerase in molecular grade water to give final concentrations 
of 1 x Reaction buffer and 1 µM primers. The mixture was then amplified  (60s at 95oC;  n 
cycles (Tables S1 [single-step] and S5 [SELEX]) of 95oC for 15 seconds, 60oC for 15 seconds, 
72oC for 10 seconds; final extension at 72oC for 60s). PCR products were transferred to 10 
mM Tris buffer using a MinElute PCR Purification Kit and 189 bp DNA was isolated with a 
Pippin Prep running a 2% agarose cassette. Isolated DNA was transferred back into 20 µl of 
10 mM Tris buffer using the MinElute kit, and characterized for size by micro-
electrophoresis on a Bioanalyzer 2100, and concentration with a Qubit Fluorometer. 
 
Table S3 Primers for nested PCR; 454 sequencing primers in bold type with MID sequences 
(barcodes) underlined.  
 
Barcode  Sequence  
 
MID  1   5’-CGTATCGCCTCCCTCGCGCCATCAGACGAGTGCGTAGATGCCTGTCGAGCATGCT 
MID 2  5’-CGTATCGCCTCCCTCGCGCCATCAGACGCTCGACAAGATGCCTGTCGAGCATGCT 
MID 3  5’-CGTATCGCCTCCCTCGCGCCATCAGAGACGCACTCAGATGCCTGTCGAGCATGCT 
MID 4  5’-CGTATCGCCTCCCTCGCGCCATCAGAGCACTGTAGAGATGCCTGTCGAGCATGCT  
MID 5  5’-CGTATCGCCTCCCTCGCGCCATCAGATCAGACACGAGATGCCTGTCGAGCATGCT 
MID 8  5’-CTATGCGCCTTGCCAGCCCGCTCAGCTCGCGTGTCCCCGTCGACAAAGCAGTTTAGCTAC 
MID 10  5’-CTATGCGCCTTGCCAGCCCGCTCAGTCTCTATGCGCCCGTCGACAAAGCAGTTTAGCTAC 
MID 11  5’-CTATGCGCCTTGCCAGCCCGCTCAGTGATACGTCTCCCGTCGACAAAGCAGTTTAGCTAC 
MID 13  5’CTATGCGCCTTGCCAGCCCGCTCAGCATAGTAGTGCCCGTCGACAAAGCAGTTTAGCTAC 
MID 14  5’-CTATGCGCCTTGCCAGCCCGCTCAGCGAGAGATACCCCGTCGACAAAGCAGTTTAGCTAC 
 
Table 4 SELEX: barcodes of sequencing primers (see Table S3) and numbers of nested PCR 
cycles used to attach sequencing primers. 
 
Round   Sense Primer     Antisense Primer      n 
  
1  MID 1   MID 8   3 
2   MID 2   MID 10  3 
3   MID 3   MID 11  3 
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4   MID 4   MID 13  6 
5  MID 5   MID 14  6 
Motif Finding Informatics 
Sequencing reads were sorted into sets by barcode and then processed by removing the 5’ 
and 3’ aptamer sequences using cutadapt.S4 Any trimmed sequences that were not 30 bases 
long were discarded. Duplicate sequences were also discarded in the single-step method, 
but not in SELEX. The remaining sequences were searched with MEME using the command 
line: meme ../file.txt -dna -maxsize 600000 -mod zoops -nmotifs 10 -minw 4 -maxw 40, 
where file.txt is a Plain Text file containing the sequences to be searched in numbered fasta 
format.  MEME is a computational tool for discovering motifs in a group of related DNA or 
protein sequences. The on-line version imposes a ceiling of <2000 on the maximum number 
of 30 base sequences that can be searched and therefore it was downloaded onto a Linux 
machine.  There is no upper limit to the number of sequences that can be searched locally 
with the downloaded version of MEME, but the computational cost of analyzing a complete 
set of sequences (all sequences from one cycle of single step selection, or one round of 
SELEX) with MEME is prohibitive and therefore sets of they were divided into sub-sets of 
≤10,000 sequences to derive intermediate motifs. Each search of a sub-set produced slightly 
different but highly similar intermediate motifs. Sequences with similar motifs were 
extracted and merged in a single file that was searched to identify final motifs. The position 
of the final motifs in the 30 base sequence was plotted against abundance (number of 
sequences with motifs divided by the total number of sequences in the set) and then 
sequences with the motif located at the Gaussian mean were extracted. The consensus of 
the extracted sequences was found with Clustal Omega, and secondary structures were 
determined with mfold applying the conditions: 25oC, 125 mM NaCl and 1 mM MgCl.  
 
Thrombin Inhibition Assays 
Thermally conditioned aptamers (Table S5) in HEPES buffer were mixed with thrombin in 
HEPES buffer to a final concentration of 1 nM thrombin and allowed to stand for one hour at 
25oC. 225 µl of this solution was added to the wells of a plate in triplicate and then 25 µl of 
fibrinogen in HEPES (centrifuged for 10 minutes at 10,000 x g immediately before addition) 
was added to each well to a final concentration of 1mg ml-1. Conversion of fibrinogen to 
fibrin at 25oC was monitored by measuring the increase in optical density at 350 nm.  
 
Table S5 Sequences of aptamers investigated in affinity and inhibition assays; the sequences 
of APT-15 and APT-29 in bivalent aptamers are underlined. 
 
Bivalent aptamer based on linker 1 
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5’- 
AGATGCCTGTCGAGCATGCTGGTTGGTGTGGTTGGATTGGGGGGCAGAATGCCAGTTTAGCGTACA
GTCCGTGGTAGGGCAGGTTGGGGTGACTGTAGCTAAACTGCTTTGTCGACGGG 
 
 
Bivalent aptamer based on linker 2 
5’-
AGATGCCTGTCGAGCATGCTGGTTGGTGTGGTTGGTTGGTTGGCGTTCAAAGCAGTCTTGGGCTAA
GTCCGTGGTAGGGCAGGTTGGGGTGACTGTAGCTAAACTGCTTTGTCGACGGG 
Bivalent aptamer based on linker 3 
5-
AGATGCCTGTCGAGCATGCTGGTTGGTGTGGTTGGGTAGGGGCCCAGCATGACAGTTTTTGCCAAA
GTCCGTGGTAGGGCAGGTTGGGGTGACTGTAGCTAAACTGCTTTGTCGACGGG 
Bivalent aptamer based on linker 4 
5’-
AGATGCCTGTCGAGCATGCTGGTTGGTGTGGTTGGGTTGTGGGGAATAAAAGCAGTTTAGCGTACA
GTCCGTGGTAGGGCAGGTTGGGGTGACTGTAGCTAAACTGCTTTGTCGACGGG 
Bivalent aptamer based on linker 5 
5’-
AGATGCCTGTCGAGCATGCTGGTTGGTGTGGTTGGAAGTAGGTGGTTCAAAGCAGTGAAGGGTAC
AGTCCGTGGTAGGGCAGGTTGGGGTGACTGTAGCTAAACTGCTTTGTCGACGGG 
Bivalent aptamer based on linker 6 
5’-
AGATGCCTGTCGAGCATGCTGGTTGGTGTGGTTGGCGGGGGCCCTCTATAGTTGCGTTCTGGATGA
GTCCGTGGTAGGGCAGGTTGGGGTGACTGTAGCTAAACTGCTTTGTCGACGGG 
TBV-08 
5’-
AGCAGCACAGAGGTCAGATGGGTTGGTGTGGTTGGTGAGACCTTGCATGCGACTTGGTGAGCACGT
GAGAAGTCCGTGGTAGGGCAGGTTGGGGTGACTCCTATGCGTGCTACCGTGAA 
 
Apt-15  
5’-GGTTGGTGTGGTTGG 
 
Apt-29 
5’-AGTCCGTGGTAGGGCAGGTTGGGGTGACT 
 
Bivalent aptamer based on linker 2 minus sense primer 
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5’-
GGTTGGTGTGGTTGGTTGGTTGGCGTTCAAAGCAGTCTTGGGCTAAGTCCGTGGTAGGGCAGGTTG
GGGTGACTGTAGCTAAACTGCTTTGTCGACGGG 
 
 
Bivalent aptamer based on linker 2 minus antisense primer 
 
5’-
AGATGCCTGTCGAGCATGCTGGTTGGTGTGGTTGGTTGGTTGGCGTTCAAAGCAGTCTTGGGCTAA
GTCCGTGGTAGGGCAGGTTGGGGTGACT 
 
Bivalent aptamer based on linker 2 minus sense and antisense primers 
5’-
GGTTGGTGTGGTTGGTTGGTTGGCGTTCAAAGCAGTCTTGGGCTAAGTCCGTGGTAGGGCAGGTTG
GGGTGACT 
 
Linker 2 
 
5’-TTGGTTGGCGTTCAAAGCAGTCTTGGGCTA 
 
Aptamer Affinity Assays 
Multiwell plates (Nunc Maxisorp) were coated overnight at 4oC with 100 µl per well of 0.5 
µg ml-1 thrombin in PBS. Wells were washed with 3 x 250 µl of 40 mM HEPES, pH 7.5, 
containing 0.05% Tween-20 (HEPES-Tween) and blocked for one hour at 25oC by gentle 
shaking with 250 µl per well HEPES-Tween containing 1 mg ml-1 BSA and 0.1 mg ml-1 salmon 
sperm DNA. Wells were washed with 3 x 250 µl of HEPES-Tween and then 100 µl of 
thermally conditioned 5’-biotin aptamer (Table S5) in HEPES buffer was incubated in the 
wells for one hour with shaking.  Wells were washed with 3 x 250 µl of HEPES-Tween and 
then 100 µl of streptavidin peroxidase diluted 1:100 in HEPES-Tween was incubated in the 
wells for one hour with shaking. Wells were washed with 4 x 250 µl HEPES-Tween and then 
200 µl of TMB solution was incubated in the wells with shaking for 10 minutes (20 minutes 
for Apt-15). The enzyme reaction was stopped by addition of 50 µl per well of 1M H2SO4 and 
the absorbance was measured at 450 nm.  
 
Supplementary Results  
 
Biotin-Thrombin 
The UV/vis spectrum of purified biotin-PEG-thrombin diluted 1:4 with 50mM sodium citrate 
buffer, pH 6.5, is shown in Figure S1a; the concentration of thrombin was 0.49 mg ml-1 (13.2 
µM). The UV/vis spectrum of purified biotin-PEG-HSA diluted 1:4 is shown in Figure S1b;  the 
concentration of HSA was 0.66mg ml-1 (9.85 µM). 
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Figure S1 a) UV/vis spectrum of biotin-PEG-thrombin. b) UV/vis spectrum of biotin-PEG-HSA. 
c) Calibration curve for HABA-avidin with biotin. 
 
Biotin Assay 
The calibration curve for biotin with avidin and HABA is shown in Figure S1c; addition of 10 
µl of undiluted biotin-PEG-thrombin to 100 µl of HABA-avidin solution produced a 4.8 µM 
solution of thrombin and absorbances at 500 nm of: 1) 0.689; 2) 0.692. Reading from the 
calibration curve the decrease in absorbance corresponds to a biotin concentration of 3.3 
µM and therefore the molar ratio of biotin to thrombin was 0.69:1. Therefore some 
molecules of thrombin were not conjugated to biotin, but the remaining molecules were 
conjugated to a low ratio of biotin-PEG. Addition of biotin-PEG-HSA to HABA-avidin solution 
showed that the ratio of biotin to HSA was 0.84:1.  
 
Single-Step Selection 
PAGE of DNA amplified from supernatants and retained on beads is shows in Figure S2. 
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Figure S2 15% poly-acrylamide gel developed at 200 V for one hour and stained with silver. 
Key: Lanes 1-9 show PCR products from supernatants 1–9; Lane 10 shows PCR products 
from DNA retained on beads.  
 
SELEX 
The workflow for SELEX is shown in Figure S3. PCR of combinatorial libraries occurs in two 
phases.S5 In the first phase products of the correct length are produced and in the second 
phase these products disappear accompanied by the formation of longer products that 
appear as a smear in PAGE. 
 
Figure S3 Scheme of SELEX. Key: size selection = preparative electrophoresis; QC = quality 
control; NGS = next generation sequencing.  
 
To obtain good yields of products with the correct length we carried out PCR in two stages. 
In the first stage DNA bound to the beads was amplified for 10 cycles and in the second 
stage products from the first stage were amplified for a further n cycles where n = 3, 6, 9, 12 
or 15 cycles. Products were characterized by PAGE as shown in Figure S4a, and then further 
PCRs were carried out for the lowest number of cycles that produced a good yield of specific 
products. The products of these PCRs were extracted by preparative electrophoresis on 
lanes 1–4 of a 2% agarose gel as shown in Figure S4b.     
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Figure S4 a) 15% poly-acrylamide gel developed at 100 V for two hours and stained with 
silver showing PCR products from Round 2 of SELEX; products produced by +3 cycles of PCR 
(red rectangle) were selected for preparative electrophoresis. Key: L = 20 bp ladder; white 
numerals = number PCR cycles where 10 is the product of the first stage PCR, and +3, +6, +9, 
+12 and +15 are the products of the second stage PCR. b) Results of preparative 
electrophoresis showing band centered on 119 bp that was extracted surrounded by white 
rectangles. Key: white numerals indicate lane numbers (lane 5 has calibrator DNA of lengths 
20, 75, 150, 300 and 600 bp); screen E shows ethidium bromide fluorescence versus time; 
screen G shows a fluoresce image of the developed agarose gel.  
 
Preparation Of Single-Step And SELEX Samples For Sequencing  
454 sequencing primers were attached by nested PCR of as shown in Figure S5a. PCR trials 
were carried out to determine the number of cycles that produced a band at 189 bp with 
minimal non-specific products as shown in Figure S5b. PCR products amplified for this 
number of cycles were transferred into Tris buffer and then a band centered on 189 bp was 
extracted by preparative electrophoresis as shown in Figure S5c. The concentrations of 
extracted products are shown in Table S6 (single-step) and S7 (SELEX) and size profiles of 
extracted products are show in Figure S6 (single-step) and Figure S7 (SELEX). 
 
 
 
Figure S5 a) Scheme of nested PCRs for attachment of 454 sequencing primers. b) 12% poly-
acrylamide gel developed at 200 V for 45 minutes and stained with silver showing PCR trials 
to find number of cycles required to produce a band at 198 bp with minimal non-specific 
products. In the example shown products produced by 6 cycles of PCR enclosed in red 
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rectangle were selected for preparative electrophoresis. Key: L = 20 bp ladder; white 
numerals = number of nested PCR cycles. c) Preparative electrophoresis on lanes 1 – 4 with 
extraction of a band centered on 189 bp (enclosed in white rectangle).  Key: white numerals 
indicate lane numbers (lane 5 has calibrator DNA of lengths 20, 75, 150, 300 and 600 bp); 
screen E shows ethidium bromide fluorescence versus time; screen G shows a fluoresce 
image of the developed agarose gel.  
 
Table S6 Concentrations of DNA in sequencing samples from single-step selection. 
 
Cycle   ng/µl    Cycle  ng/ µl 
 
1  56.4    6  59.9 
 
2  53.9    7  18.4 
 
3  31.7    8  44.6 
 
4  30.5    9  72.6 
 
5  13.4    Beads  73.2 
 
 
Table S7 Concentrations of DNA in sequencing samples from SELEX. 
 
Round  ng/ µl  
    
1  81.0    
 
2  48.6   
 
3  23.7   
 
4  85.8   
 
5  11.1   
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Figure S6 Micro-electrophoresis size-profiles of samples from single-step selection that were 
sequenced. Peaks at 35 bp and 10,350 are internal calibrators. 
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Figure S7 Micro-electrophoresis size-profiles of samples from SELEX that were sequenced. 
Peaks at 35 bp and 10,350 are internal calibrators. 
 
Lowest Energy Secondary Structures 
Lowest energy secondary structures of the bivalent aptamers returned by mfold are shown 
in Figure S8 (bivalent aptamers based on linkers 1-3) and Figure S9 (bivalent aptamers based 
on linkers 4-6. Note that G-quadruplexes in the structures of APT-15 and Apt-29 are not 
recognized by mfold, and G-T base pairs that are returned by mfold have been removed 
from the structures. 
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Figure S8 Lowest energy secondary structures of bivalent aptamers based on linkers 1-3. 
Nucleotides of Apt-15 are shown in red font and nucleotides of Apt-29 are shown in blue 
font.  
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Figure S9 Lowest energy secondary structures of bivalent aptamers based on linkers 4. 
Nucleotides of Apt-15 are shown in red font and nucleotides of Apt-29 are shown in blue 
font. Structures of bivalent aptamers based on linker 4. The free energies (ΔG’s) of 
formation in kcal mol-1 are: I = -21.64; II = -20.64; III = -20.41. 
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Figure S10 Lowest energy secondary structures of bivalent aptamers based on linkers 4 and 
5. Nucleotides of Apt-15 are shown in red font and nucleotides of Apt-29 are shown in blue 
font.  
 
Thrombin Inhibition Assays 
The increase in OD due to the thrombin-catalyzed conversion of fibrinogen to fibrin has a 
sigmoid profile where the duration of the initial lag-phase depends on the concentration of 
added the inhibitor as shown in Figure S11a. The duration of the lag-phase was determined 
by projecting the intersection of the base-line OD and the slope of the exponential phase 
onto the X-axis as shown in Figure S11b. Thrombin Inhibition curves were obtained by 
plotting the duration of the lag-phase in the absence of inhibitor divided by the duration of 
the lag-phase in the presence of inhibitor against the log10 of the inhibitor concentration. 
IC50 values were determined by projecting 50% inhibition onto the X-axis as shown for Apt-
15 in Figure S11c. Inhibition curves for Apt-15 and Apt-29 are shown in Figure S12. Inhibition 
curves for bivalent aptamers based on linkers 1–6 are shown in Figure S13. Inhibition curves 
for argatroban and the bivalent aptamer (TBV-08) identified by Soh and colleagues are 
shown in Figure S14. Inhibition curves for truncated derivatives of the bivalent aptamer 
based on linker 2 are shown in Figure S15. 
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Figure S11 a) Traces showing effect of Apt-15 on increase in OD at 350 nm due to thrombin-
catalyzed conversion of fibrinogen to fibrin. Key to Apt-15 concentrations from shortest to 
longest lag phase: 1 nM; 10 nM; 13.3 nM; 100 nM; 1000 nM. b) Trace for thrombin in the 
presence of 13.3 nM Apt-15 showing how the duration of the lag-phase was determined by 
projecting the intersection of the base-line OD and the slope of the exponential phase onto 
the X-axis (red arrow). c) Inhibition curve of Apt-15 showing how IC50 was determined by 
projecting 50% inhibition onto the X-axis (red arrow) 
 
                                                                 
 
Figure S12 Inhibition curves of Apt-15 and Apt-29. 
 
 
31 
 
 
 
Figure S13 Inhibition curves of bivalent aptamers. 
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Figure S14 Inhibition curves of bivalent aptamer TBV-08 and argatroban. 
 
Figure S15 Inhibition curves of truncated derivatives of the bivalent aptamer based on linker 
2. 
 
Aptamer Affinity Assays 
The scheme of a competed assay is shown in Figure S16a. Absorbance values due to color 
development at 450 nm were plotted against the log10 of the aptamer concentrations as 
shown for Apt-29 in Figure S16b. Concentrations corresponding to 50% affinity were 
determined by projecting 50% absorbance onto the X-axis as shown for Apt-29 in Figure 
S16b. Affinity curves for Apt-29 and Apt-15 are shown in Figure S17. Affinity curves for 
bivalent aptamers based on linkers 1–6 are shown in Fig S18. Affinity curves for truncated 
derivatives of the bivalent aptamer based on linker 2 are shown in Figure S19. 
 
 
Figure S16 a) Scheme of affinity assays. Key: SA = streptavidin; HRP = horseradish 
peroxidase; TMB = tetramethylbenzidine. b) Affinity curve for Apt-29 showing how 50% 
affinity was determined by projecting 50% absorbance onto the X-axis (red arrow) 
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Figure S17 Affinity curves of Apt-29 and Apt-15. 
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Figure S18 Affinity curves of bivalent aptamers. 
 
Figure S19 Affinity curves of truncated derivatives of the bivalent aptamer based on linker 2. 
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